Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
Alignment Healthcare Inc (NASDAQ: ALHC) closed the day trading at $14.40 down -1.17% from the previous closing price of $14.57. In other words, the price has decreased by -$1.17 from its previous closing price. On the day, 2.21 million shares were traded. ALHC stock price reached its highest trading level at $14.685 during the session, while it also had its lowest trading level at $14.3301.
Ratios:
For a better understanding of ALHC, let’s look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 3.05 whereas as Long-Term Debt/Eq ratio is at 3.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stephens on December 03, 2024, Upgraded its rating to Overweight and sets its target price to $17 from $13 previously.
BofA Securities Upgraded its Neutral to Buy on May 30, 2024, whereas the target price for the stock was revised from $7.75 to $11.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 16 ’25 when KAO JOHN E sold 90,000 shares for $14.48 per share. The transaction valued at 1,302,849 led to the insider holds 1,733,100 shares of the business.
Maroney Dawn Christine sold 30,000 shares of ALHC for $434,280 on Jun 16 ’25. The President now owns 2,072,899 shares after completing the transaction at $14.48 per share. On Jun 16 ’25, another insider, JEK TRUST U/A DTD 02/08/2021, who serves as the Director of the company, bought 560,000 shares for $14.94 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALHC now has a Market Capitalization of 2848939264 and an Enterprise Value of 2699767296. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.95 while its Price-to-Book (P/B) ratio in mrq is 26.32. Its current Enterprise Value per Revenue stands at 0.899 whereas that against EBITDA is -79.604.
Stock Price History:
The Beta on a monthly basis for ALHC is 1.22, which has changed by 1.0310297 over the last 52 weeks, in comparison to a change of 0.092761636 over the same period for the S&P500. Over the past 52 weeks, ALHC has reached a high of $21.06, while it has fallen to a 52-week low of $7.05. The 50-Day Moving Average of the stock is -11.18%, while the 200-Day Moving Average is calculated to be 3.99%.
Shares Statistics:
Over the past 3-months, ALHC traded about 3.34M shares per day on average, while over the past 10 days, ALHC traded about 2549200 shares per day. A total of 197.67M shares are outstanding, with a floating share count of 130.99M. Insiders hold about 33.79% of the company’s shares, while institutions hold 59.24% stake in the company. Shares short for ALHC as of 1748563200 were 9760558 with a Short Ratio of 2.92, compared to 1745971200 on 10395565. Therefore, it implies a Short% of Shares Outstanding of 9760558 and a Short% of Float of 7.6.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
At present, 5.0 analysts are actively evaluating the performance of Alignment Healthcare Inc (ALHC) in the stock market.The consensus estimate for the next quarter is -$0.02, with high estimates of $0.0 and low estimates of -$0.07.
Analysts are recommending an EPS of between $0.03 and -$0.02 for the fiscal current year, implying an average EPS of $0.01. EPS for the following year is $0.17, with 4.0 analysts recommending between $0.21 and $0.08.
Revenue Estimates
9 analysts predict $960.25M in revenue for the current quarter. It ranges from a high estimate of $965M to a low estimate of $955.3M. As of the current estimate, Alignment Healthcare Inc’s year-ago sales were $681.29MFor the next quarter, 9 analysts are estimating revenue of $956.15M. There is a high estimate of $966.5M for the next quarter, whereas the lowest estimate is $947.9M.
A total of 9 analysts have provided revenue estimates for ALHC’s current fiscal year. The highest revenue estimate was $3.82B, while the lowest revenue estimate was $3.78B, resulting in an average revenue estimate of $3.8B. In the same quarter a year ago, actual revenue was $2.7BBased on 10 analysts’ estimates, the company’s revenue will be $4.81B in the next fiscal year. The high estimate is $5.01B and the low estimate is $4.63B.
